These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28264447)

  • 1. The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.
    Garrido F; Perea F; Bernal M; Sánchez-Palencia A; Aptsiauri N; Ruiz-Cabello F
    Vaccines (Basel); 2017 Feb; 5(1):. PubMed ID: 28264447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.
    Aptsiauri N; Ruiz-Cabello F; Garrido F
    Curr Opin Immunol; 2018 Apr; 51():123-132. PubMed ID: 29567511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targetless T cells in cancer immunotherapy.
    Thor Straten P; Garrido F
    J Immunother Cancer; 2016; 4():23. PubMed ID: 27096099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.
    Perea F; Sánchez-Palencia A; Gómez-Morales M; Bernal M; Concha Á; García MM; González-Ramírez AR; Kerick M; Martin J; Garrido F; Ruiz-Cabello F; Aptsiauri N
    Oncotarget; 2018 Jan; 9(3):4120-4133. PubMed ID: 29423109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting HLA class I expression to increase tumor immunogenicity.
    del Campo AB; Carretero J; Aptsiauri N; Garrido F
    Tissue Antigens; 2012 Mar; 79(3):147-54. PubMed ID: 22309256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA Class-I Expression and Cancer Immunotherapy.
    Garrido F
    Adv Exp Med Biol; 2019; 1151():79-90. PubMed ID: 31140107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
    del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
    Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.
    Aptsiauri N; Carretero R; Garcia-Lora A; Real LM; Cabrera T; Garrido F
    Cancer Immunol Immunother; 2008 Nov; 57(11):1727-33. PubMed ID: 18491093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes.
    Aptsiauri N; Garrido F
    Clin Cancer Res; 2022 Dec; 28(23):5021-5029. PubMed ID: 35861868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection versus escape: the tumor MHC dilemma.
    Garrido F; Ruiz-Cabello F; Aptsiauri N
    Cancer Immunol Immunother; 2017 Feb; 66(2):259-271. PubMed ID: 28040849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
    Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC/HLA Class I Loss in Cancer Cells.
    Garrido F
    Adv Exp Med Biol; 2019; 1151():15-78. PubMed ID: 31140106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.
    Al-Sukaini A; Hornicek FJ; Peacock ZS; Kaban LB; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2017 Dec; 475(12):3071-3081. PubMed ID: 28725958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Immunology: Immune Escape of Tumors-Expression and Regulation of HLA Class I Molecules and Its Role in Immunotherapies.
    Wang Y; Jasinski-Bergner S; Wickenhauser C; Seliger B
    Adv Anat Pathol; 2023 May; 30(3):148-159. PubMed ID: 36517481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
    Dierssen JW; de Miranda NF; Ferrone S; van Puijenbroek M; Cornelisse CJ; Fleuren GJ; van Wezel T; Morreau H
    BMC Cancer; 2007 Feb; 7():33. PubMed ID: 17316446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation.
    Rodríguez JA
    Oncol Lett; 2017 Oct; 14(4):4415-4427. PubMed ID: 29085437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urgent need to recover MHC class I in cancers for effective immunotherapy.
    Garrido F; Aptsiauri N; Doorduijn EM; Garcia Lora AM; van Hall T
    Curr Opin Immunol; 2016 Apr; 39():44-51. PubMed ID: 26796069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.